UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 10, 2013
Apria Healthcare Group Inc.
(Exact name of registrant as specified in its charter)
Delaware | 333-168159 | 33-0488566 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
26220 Enterprise Court Lake Forest, California |
92630 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (949) 639-2000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Departure and Election of Directors
On December 10, 2013, Michael Dal Bello resigned from his position as a member of the Board of Directors (the Board) of Apria Healthcare Group Inc. (the Company). The Company is grateful to Mr. Dal Bello for his dedicated service to the Board.
On December 13, 2013, Daniel J. Starck, the Chief Executive Officer of the Companys home respiratory therapy and home medical equipment segment, was elected to the Board, filling the vacancy created by the resignation of Mr. Dal Bello.
Departure of Principal Financial Officer
In accordance with the terms of the Revised Compensation Agreement dated as of February 19, 2013 between Peter A. Reynolds and the Company (the Compensation Agreement), the employment of Peter A. Reynolds, the Companys Chief Accounting Officer and principal financial officer, will terminate on December 31, 2013. The Compensation Agreement was previously filed with the Securities and Exchange Commission as Exhibit 10.40 to the Companys Annual Report on Form 10-K filed on March 11, 2013.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
APRIA HEALTHCARE GROUP INC. | ||||||||||
Date: December 16, 2013 | By: | /s/ Robert S. Holcombe | ||||||||
Name: | Robert S. Holcombe | |||||||||
Title: | Executive Vice President, General Counsel and Secretary |